Why it was recalled
Presence of foreign substance.
Product description
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
Lot numbers, UPCs & expiration codes
L2300594
Where it was sold
IL, MS, OH
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0583-2024
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jun 7, 2024
- FDA report date
- Jul 10, 2024
- Quantity
- 20,520 units
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
Original FDA data
Every field from FDA enforcement report D-0583-2024, exactly as published.
Show all FDA fields
- City
- Princeton
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 94781
- Address
- 107 College Rd E
- Code information
- L2300594
- Postal code
- 08540-6623
- Report date
- Jul 10, 2024
- Product type
- Drugs
- Recall number
- D-0583-2024
- Classification
- Class II
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Product quantity
- 20,520 units
- Termination date
- Dec 22, 2025
- Reason for recall
- Presence of foreign substance.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
- Distribution pattern
- IL, MS, OH
- Recall initiation date
- Jun 7, 2024
- Initial firm notification
- Letter
- Center classification date
- Jul 3, 2024